The global consulting firm McKinsey and Company Friday agreed to pay $650 million to settle a federal probe into its role in helping "turbocharge" sales of the highly addictive opioid painkiller OxyContin for Purdue Pharma, the U.S. Justice Department announced on Friday.
Federal officials said the influential consulting company - which often advises governments and powerful corporations around the globe - committed crimes while trying to aggressively boost opioid sales.
"It was a strategy, it was executed and it worked," said U.S. attorney Christopher Kavanaugh during a press conference on Friday. "McKinsey's strategy resulted in prescriptions for Oxycontin that were unsafe and medically unnecessary."
When the FDA announced a ban of food dye Red No. 3 this week, the agency...
US regulators on Wednesday banned the dye called Red 3 from the nation’s food supply, nearly...
Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of...
